Ovarian conservation and hormone receptors in uterine Müllerian adenosarcomas.

Immunohistochemical determination of hormone receptors in uterine adenosarcomas. Gynecol Oncol (2003) 1.39

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84

Use of the levonorgestrel-releasing intrauterine system in breast cancer patients. Fertil Steril (2007) 1.48

Primary small cell neuroendocrine tumour of the breast. Eur J Obstet Gynecol Reprod Biol (2004) 1.10

Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome Sci (2009) 1.10

The value of AFP in congenital cervical teratoma. J Pediatr Surg (2003) 1.02

Cervical adenocarcinoma: moving towards better prevention. Vaccine (2011) 0.93

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer (2004) 0.89

Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma. PLoS One (2011) 0.84

Don't forget HPV-45 in cervical cancer screening. Am J Clin Pathol (2012) 0.82

Intimate examination teaching with volunteers: implementation and assessment at the University of Antwerp. Patient Educ Couns (2006) 0.81

The rapid development of a giant condyloma acuminatum (Buschke-Löwenstein tumor) during pregnancy. Acta Obstet Gynecol Scand (2007) 0.80

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Lancet (2003) 0.79

Horner's syndrome: an ominous sign in breast cancer. Eur J Obstet Gynecol Reprod Biol (2006) 0.79

Suspicious nipple discharge and breast magnetic resonance imaging. Breast J (2004) 0.78

Anal human papillomavirus DNA in women at a colposcopy clinic. Eur J Obstet Gynecol Reprod Biol (2012) 0.78

Three pathognomonic signs of a laparoscopic complication. Acta Obstet Gynecol Scand (2005) 0.77

The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol (2005) 0.77

Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance? Maturitas (2006) 0.76

The rationale for mTOR inhibition in epithelial ovarian cancer. Expert Opin Investig Drugs (2009) 0.76

Treatment of Aggressive Pelvic Fibromatosis With Interferon. Obstet Gynecol (2015) 0.76

Tjalma's syndrome. Lancet (2006) 0.76

Extramammary Paget's disease of the vulva. J Am Coll Surg (2003) 0.75

Letter to the Editor referring to the manuscript entitled: "Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications." reported by Valari O, et al., (Gynecol Oncol 2011; 122(3): 505-8). Gynecol Oncol (2012) 0.75

Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol (2006) 0.75

The missing ink. Eur J Obstet Gynecol Reprod Biol (2007) 0.75

Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35? Eur J Cancer (2005) 0.75

False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques. Gynecol Oncol (2004) 0.75

Pitfall of the missing swab. Gynecol Oncol (2004) 0.75

The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors. Eur J Obstet Gynecol Reprod Biol (2005) 0.75

HPV 18 antibody levels, clinical efficacy and induced immune memory: a trio? Vaccine (2009) 0.75

Abandon the intrauterine catheter and delay the cerclage in a radical trachelectomy. Gynecol Oncol (2007) 0.75